Skip to content

Released Oct 23, 2026, before the open

10-Q filed Oct 23, 2026, 23 days after period end · 0000009326-26-000035

Q3 2026 · 10-Q
Revenue$290.66M+8.6% vs Q3 2025+2.3% vs Q2 2026
Net Income$46.73M+16.0% vs Q3 2025+4.7% vs Q2 2026
EPS Diluted$1.46+17.7% vs Q3 2025+5.0% vs Q2 2026
Gross Profit$105,714,000+10.7%
Operating Income$62,437,000+14.4%
Operating Cash Flowderived$69,772,000+6.4%
Margins · derived
Gross margin36.4%+0.7 pt vs Q3 2025
Operating margin21.5%+1.1 pt vs Q3 2025
Net margin16.1%+1.0 pt vs Q3 2025

What the release said

On October 23, 2026, Balchem Corporation reported earnings for the quarter ended September 30, 2026, and certain other information.

Balchem reported third quarter 2026 net sales of $290.7 million, up 8.6%, and GAAP net earnings of $46.7 million, up 16.0%, from the prior year quarter.234

GAAP earnings per share were $1.46 compared to $1.24 in the prior year quarter, and adjusted earnings per share were $1.57 compared to $1.35.5

Balchem repurchased approximately $28 million of common stock during the third quarter and approximately $127 million over the trailing twelve months.6

As of September 30, 2026, the revolving loan outstanding was $124.0 million and net debt was $57.7 million, with a leverage ratio on a net debt basis of 0.2 times.7

Net sales
$290.7 million2
GAAP net earnings
$46.7 million2
Adjusted EBITDA
$80.3 million2
GAAP earnings per share
$1.465
Adjusted earnings per share
$1.575
Free cash flow
$57.9 million8
Thaler Agent · checked against the filing
Open the reading ›
The release

Same quarter

MetricQ3 2026Q3 2025Q3 2024Q3 2023
Revenue$290.66M$267.56M$239.94M$229.95M
Net Income$46.73M$40.29M$33.84M$29.08M
EPS Diluted$1.46$1.24$1.03$0.90

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Balchem Corp · CIK 9326 · Engraved from SEC EDGAR